Elsevier

Human Pathology

Volume 45, Issue 6, June 2014, Pages 1199-1204
Human Pathology

Original contribution
The pulmonary histopathologic manifestations of the anti-PL7/antithreonyl transfer RNA synthetase syndrome

https://doi.org/10.1016/j.humpath.2014.01.018Get rights and content

Summary

The pulmonary histopathologic manifestations of the antisynthetase syndromes is poorly understood and reported. Eight cases of interstitial lung disease related to the presence of antitheonyl (PL7) transfer RNA synthetase autoantibodies along with a review of biopsy changes reported in the English literature are described. Most patients presented with dyspnea and cough, with myositis, skin changes including “mechanic's hands,” and Raynaud phenomenon. Biopsy patterns of injury included usual interstitial pneumonia (n = 4), organizing pneumonia (n = 2), nonspecific interstitial pneumonia, and lymphoid interstitial pneumonia (n = 1 each), which, in a minority of instances, contrasted with predictions by thoracic radiologists based on high-resolution computed tomographic scans. This study emphasizes the integrated clinical, radiologic, and pathologic approach to interstitial lung disease, especially in connective tissue disorders, and points out the occurrence of usual interstitial pneumonia and organizing pneumonia in this patient group where nonspecific interstitial pneumonia has been the dominant pattern of clinical interest.

Introduction

The lung is the most frequent extramuscular organ afflicted in the idiopathic inflammatory myopathies including polymyositis and dermatomyositis (DM). Clinical respiratory signs and symptoms can derive from respiratory muscle weakness, infectious complications, aspiration due to oropharyngeal dysfunction, or complications of immunosuppressive therapy [1], [2], [3], [4], [5]. The association of interstitial lung disease (ILD) and the myositis spectrum of disease is well known, and the incidence varies depending on the subclassification of the syndrome and autoantibody profiles [6], [7], [8], [9], [10], [11]. The highest incidence occurs in the so-called antisynthetase syndrome (ASS) in which patients have autoantibodies that target aminoacyl transfer RNA synthetases that catalyze the binding of specific amino acids to their cognate transfer RNA during protein synthesis [1]. Patients often present with myositis, ILD, arthritis, Raynaud phenomenon, fever, and mechanic's hands with variations in incidence dependent on the unique antiaminoacyl transfer RNA synthetase antibody [1], [3]. Anti-Jo1 (antihistidyl transfer RNA synthetase) is the most common autoantibody in this group and is associated with pulmonary disease in more than 70% of cases [1], [12]. Others include anti-PL7 (antithreonyl), anti-PL12 (antialanyl), anti-OJ (anti-isoleucyl), anti-EJ (antiglycyl), and anti-KS (antiasparaginyl), among others. Although anti-Jo1 occurs in 20% to 30% of ASSs, the second most common, anti-PL7 (antithreonyl) occurs in 3% to 17% of cases and also has a high incidence of clinical ILD [13], [14], [15], [16], [17], [18], [19]. Despite its relative frequency and its involvement of the lung, the pulmonary pathology of anti-PL7 synthetase syndrome (APL7SS) has been poorly described, with few biopsy reported cases in the literature [13], [14], [15], [16]. In this study, we report the largest study of the pulmonary histopathology of anti-PL7 pulmonary disease in conjunction with a review of the reported biopsy findings in the English literature.

Section snippets

Materials and methods

The University of Pittsburgh Connective Tissue Disease (CTD) Registry encompasses more than 3 decades of prospective data and serum collected on consecutive outpatients and inpatients with various autoimmune diseases evaluated at the University of Pittsburgh [1]. All variables (clinical, laboratory, radiographic, and pathologic) as well as organ system definitions are well defined and standardized in this registry. The antisynthetase antibody group included patients in the CTD registry who were

Clinical presentation

The clinical features of the 8 patients with clinical APL7SS are shown in Table 1. Five patients were women; 3 were men. All except 1 were white. Mean age was 54 years (range, 36-83 years). Most patients presented with cough (n = 5) or dyspnea on exertion (n = 3). Myositis was present in 5 patients based on proximal muscle weakness or abnormal muscle enzymes. Skin changes of DM were noted in 5 patients, and “mechanic's hands” were present in 3. Sclerodactyly was not noted in any patient.

Discussion

Idiopathic inflammatory myopathies such as DM and polymyositis may affect many organs beyond skeletal muscle and skin. Involvement of these other sites is unpredictable but is related to the autoantibodies associated with myopathy. In particular subsets of inflammatory myopathy—the ASSs—are associated with a variety of antibodies directed at the aminoacyl transfer RNA synthetases responsible for the attachment of amino acids to cognate transfer RNA, and they have a high incidence of pulmonary

References (24)

  • Y. Hamaguchi et al.

    Common and distinct clinical features in adult patients with anti–aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome

    PLoS One

    (2013)
  • A. Labirua et al.

    Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls

    Curr Opin Rheumatol

    (2010)
  • Cited by (26)

    • Myositis-associated interstitial lung disease

      2024, Revista Colombiana de Reumatologia
    • Pulmonary histopathology of interstitial lung disease associated with antisynthetase antibodies

      2022, Respiratory Medicine
      Citation Excerpt :

      Historically, these patients have been considered poor biopsy candidates, and radiographic patterns have often been used to surmise the underlying pathology. However, pulmonary radiographic and biopsy findings often disagree [17–19]. For example, in one series, a CT pattern initially suggestive of fibrotic NSIP in 12 patients correlated with findings of UIP on lung biopsy in 4 of these [77].

    • Myositis in clinical practice—relevance of new antibodies

      2018, Best Practice and Research: Clinical Rheumatology
      Citation Excerpt :

      Antisynthetase antibodies have been reported with different patterns of lung pathology. In 8 patients with anti-PL-7, lung histology showed usual interstitial pneumonia (UIP) (n = 4), organizing pneumonia (n = 2), nonspecific interstitial pneumonia (n = 1), and lymphoid interstitial pneumonia (n = 1) [38], while 4 patients with anti-EJ (all amyopathic) demonstrated UIP (n = 2) and organizing diffuse alveolar damage (DAD) (n = 2) [39]. Another series of 5 patients with anti-KS reported UIP (n = 4) and organizing pneumonia (n = 1) [40].

    • Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease

      2016, Respiratory Medicine
      Citation Excerpt :

      The current study showed that the anti-ARS-positive, anti-MDA5-positive and MSA-negative groups accounted for a large percentage of PM/DM-ILD patients, whereas few or no PM/DM-ILD patients were positive for MSAs other than anti-ARS and anti-MDA5 antibodies. Anti-ARS or anti-MDA5 antibody-positive patients have been shown to have unique features [14–28,32]. Consistent with these results, we confirmed that there were characteristic clinical features in our PM/DM-ILD cohort.

    • Pulmonary complications of inflammatory myopathy

      2015, Rheumatic Disease Clinics of North America
      Citation Excerpt :

      Patients with anti–PL-7 and anti–PL-12 tend to present with a higher incidence of ILD in the absence of clinical myositis.32 A few studies found that usual interstitial pneumonia (UIP) was more common than nonspecific interstitial pneumonia (NSIP) when histopathologic diagnosis was obtained.33,34 Overall, because the other anti-ARS antibodies make up less than 2% of patients with the antisynthetase syndrome, little is known about their specific phenotypes; however, smaller case series highlight the association of several of these less frequently observed anti-ARS antibodies with ILD.35–37

    View all citing articles on Scopus

    Disclosures: There are no conflicts of interest or funding disclosures.

    View full text